Donald Beasley

Donald Beasley is currently the Executive Director and Early-stage Oncology Program Management Lead at Pfizer. Previously, they served as a Sr. Director of Portfolio & Program Management at Seagen, where they led the Program Management department. With extensive experience in the pharmaceutical industry, Donald held various key roles at Genentech, including Director of Project Management and Associate Director. They began their career at Quintiles as a Statistical Programmer and later worked as an Analyst/Programmer and Clinical Trials Project Leader at Duke Clinical Research Institute. Donald earned a Bachelor of Science in Business Administration from the University of North Carolina at Chapel Hill and an MBA from North Carolina Central University.